Stocks / NASDAQ / Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited

Our Opinion

Connect Biopharma Holdings Limited is on the Cruelty Free Investing list for exploiting animals because the company does animal testing to assess a product’s safety profile.

Company Description

Connect Biopharma Holdings Ltd is a holding company mainly engaged in the development of clinical-stage biopharmaceutical therapies for the treatment of T cell-driven inflammatory diseases. Its product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis (AD), and asthma.

Company Website: